Grants and Contributions

The objectives for the renewal align with the initial NEIHR Program funding opportunity as follows:

• Support Indigenous community-based health research that reflects the priorities and values of Indigenous Peoples;
• Enhance the Indigenous community-based health research network environment that will support Indigenous leadership and research-related organizations with existing and new research infrastructures and platforms;
• Augment awareness, capacity and relevance of Indigenous health research that improves the health of First Nations, Inuit and Métis Peoples across all health research domains;
• Improve the understanding of Indigenous health research and Indigenous research paradigms through ethical and impactful partnerships between Indigenous communities and health researchers, scholars, professors and instructors, research administrators, policy and decision makers, and other parties with an interest in Indigenous health research;
• Engage Indigenous Peoples in Canada in leading and conducting health research and Knowledge Sharing;
• Engage with researchers, Indigenous Peoples, and other relevant parties from different countries as appropriate, in order to advance the objectives of the NEIHR Centres; and
• Develop enduring NEIHR Centres with sustainable mandates to build research capacity, conduct research, advance Indigenous research paradigms, and carry out Knowledge Sharing activities.

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge

The CIHR Institute of Infection and Immunity (CIHR-III) has a mandate to support research,build research capacity and mobilize knowledge in the areas of infectious disease and the body's immune system. This priority announcement has a primary focus on biomedical research in which the objective and aims are directed towards building foundational knowledge in immunology and/or infectious diseases. Funding will be provided for applications that specifically align with III’s mandate and one or more of the following priority areas:

• Infection:
o Zoonotic or vector-borne transmission of pathogens in the context of Global Climate Change;
o Understanding functional genomics and/or molecular epidemiology of emerging/re-emerging pathogens;
o Resistance to fungal infections and/or the role of bacteriophages in combatting antimicrobial resistance.
• Immunity:
o Immune mechanisms involved in the development of trained innate immunity;
o Immune mechanisms involved in the development and maintenance of tissue-specific immunity;
o Metabolic regulation of immune cells and processes (immunometabolism).

Should there be no eligible applications relevant to the Priority Areas, applications that are relevant to the priority announcement but that fall outside of the Priority Areas would be funded.

The CIHR Institute of Infection and Immunity (CIHR-III) will offer funding to support early career researchers (ECR) in the fields of infection and immunity.

CIHR-III will award multi-year grants to applications that are determined to be specifically relevant to the CIHR-III broad mandate to support research, build research capacity and mobilize knowledge in the areas of infectious disease and the body's immune system.

The CIHR Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA) will fund applications that are determined relevant to its mandate and research priority areas as described below:

• Myalgic Encephalomyelitis
• Oral Health

Dr. Menten's outstanding career as a biomedical scientist led to many achievements including important co-discoveries relating to blood sugar, haemoglobin and kidney functions. In 1913, a collaboration with Leonor Michaelis on the behaviour of enzymes resulted in the Michaelis-Menten equation, a biochemical concept so fundamental that it is familiar to first-year science students.
This Maud Menten New Principal Investigator Prize was established to recognize and support the research excellence of Canadian Early-Career Investigators working within the mandate of the CIHR Institute of Genetics (CIHR-IG).
This prize is a supplemental grant to support research and must be used according to the CIHR Grants and Awards Guide. The prize is not a personal award and is non-renewable.
IG's Commitments
In order to achieve our mandate and vision while strongly supporting the implementation of CIHR's Strategic Plan 2021-2031 priorities, the Institute of Genetics is committing to working towards the development of four major themes. Woven with our values and principles, these commitments are the materialization of input from the broad genetics and genomics community, to patients and caregivers, to clinicians and clinician scientists, to basic biomedical researchers.
• Commitment A: Enabling Genomic Medicine
• Commitment B: Improving Genetic Disease Diagnosis and Therapies
• Commitment C: Embracing Diversity, Inclusion and Indigenous Rights
• Commitment D: Strengthening the Community

• The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.
• This priority announcement (PA) is designed to support research that mitigates the challenges experienced along the cancer survivorship journey and improves the health outcomes for cancer survivors of all ages from the time of their cancer diagnosis until the time of their death or entry into end-of-life care. This PA will not fund research focused on improving end-of-life care.
• This PA supports research that creates new knowledge in cancer survivorship and/or moves it into practice in the health system, communities, and in the daily lives of Canadians.
• This PA will fund research in the following areas:
o Late & Long-Term Effects
o Survivors’ Experiences & Outcomes
o Models of Care